1. Market Research
  2. > Pathology
88 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Lymphoblastic Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 275 pages

Lymphoblastic Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Lymphoblastic Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing Lymphoblastic

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • Pathology

Indolent Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 78 pages

Indolent Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Indolent Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing Indolent Lymphoma Trials

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • Pathology

Follicular Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 240 pages

Follicular Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Follicular Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing Follicular Lymphoma

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma

Burkitt Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 84 pages

Burkitt Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Burkitt Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing Burkitt Lymphoma Trials by

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma

Mantle Cell Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 176 pages

Mantle Cell Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Mantle Cell Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing Mantle Cell

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma

B-Cell Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 480 pages

B-Cell Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of B-Cell Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing B-Cell Lymphoma Trials by Ph

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • Pathology

AIDS - Related Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 24 pages

AIDS - Related Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of AIDS - Related Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing AIDS - Related

  • Cancer
  • Clinical Trial
  • Drug Development
  • HIV AIDS
  • Lymphoma

Natural Killer Cell Lymphomas Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 66 pages

Natural Killer Cell Lymphomas Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Natural Killer Cell Lymphomas Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing Natural K

  • Cancer
  • Cell Therapy
  • Clinical Trial
  • Lymphoma
  • Medical Biotechnology

Cutaneous B-Cell Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 60 pages

Cutaneous B-Cell Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Cutaneous B-Cell Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing Cutaneous B-Cell

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • Pathology

Cutaneous B- Cell Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 48 pages

Cutaneous B- Cell Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Cutaneous B- Cell Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing Cutaneous B- Ce

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • Pathology

Anaplastic Large Cell Lymphoma Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • June 2018
  • 72 pages

Anaplastic Large Cell Lymphoma Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Anaplastic Large Cell Lymphoma Trials ## Clinical Trials Trends to 2022 ##. ## Ongoing Anaplas

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma

2019 Lymphoblastic Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • $ 1799
  • April 2019
  • 411 pages

Lymphoblastic Lymphoma Clinical Trial Trends ##. ## Start Year wise Lymphoblastic Lymphoma Clinical Trials ##. ## Phase wise Lymphoblastic Lymphoma Clinical Trials ##. ## Trial Status wise Lymphoblastic Lymphoma Clinical Trials ##. ## Trial Type wise Lymphoblastic

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • Pathology

2019 Burkitt Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • $ 1799
  • April 2019
  • 219 pages

Burkitt Lymphoma Clinical Trial Trends ##. ## Start Year wise Burkitt Lymphoma Clinical Trials ##. ## Phase wise Burkitt Lymphoma Clinical Trials ##. ## Trial Status wise Burkitt Lymphoma Clinical Trials ##. ## Trial Type wise Burkitt Lymphoma Clinical Trials ##.

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma

2019 AIDS Related Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • $ 1799
  • April 2019
  • 43 pages

AIDS Related Lymphoma Clinical Trial Trends ##. ## Start Year wise AIDS Related Lymphoma Clinical Trials ##. ## Phase wise AIDS Related Lymphoma Clinical Trials ##. ## Trial Status wise AIDS Related Lymphoma Clinical Trials ##. ## Trial Type wise AIDS Related

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma

2019 Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • $ 1799
  • April 2019
  • 360 pages

Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Trends ##. ## Start Year wise Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trials ##. ## Phase wise Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trials ##. ## Tri

  • Cancer
  • Clinical Trial
  • Lymphoma
  • Pathology

2019 Natural Killer Cell Lymphomas Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • $ 1799
  • April 2019
  • 112 pages

Natural Killer Cell Lymphomas Clinical Trial Trends ##. ## Start Year wise Natural Killer Cell Lymphomas Clinical Trials ##. ## Phase wise Natural Killer Cell Lymphomas Clinical Trials ##. ## Trial Status wise Natural Killer Cell Lymphomas Clinical Trials ##. ## Trial Type wi

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • Medical Biotechnology

2019 Cutaneous B-Cell Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • $ 1799
  • April 2019
  • 75 pages

Cutaneous B-Cell Lymphoma Clinical Trial Trends ##. ## Start Year wise Cutaneous B-Cell Lymphoma Clinical Trials ##. ## Phase wise Cutaneous B-Cell Lymphoma Clinical Trials ##. ## Trial Status wise Cutaneous B-Cell Lymphoma Clinical Trials ##. ## Trial Type wise Cutaneous B-C

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • Pathology

2019 Anaplastic Large Cell Lymphoma (ALCL) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • $ 1799
  • April 2019
  • 136 pages

Anaplastic Large Cell Lymphoma (ALCL) Clinical Trial Trends ##. ## Start Year wise Anaplastic Large Cell Lymphoma (ALCL) Clinical Trials ##. ## Phase wise Anaplastic Large Cell Lymphoma (ALCL) Clinical Trials ##. ## Trial Status wise Anaplastic Large Cell Lymphoma (ALCL) C

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma

Burkitt Lymphoma R&D Pipeline Analysis Report, H2-2018

  • $ 2200
  • August 2018
  • 100 pages

Companies Investing in Burkitt Lymphoma Pipeline include Number of Companies with Burkitt Lymphoma projects in pre clinical Development Number of Companies with Burkitt Lymphoma projects in Clinical Development Burkitt Lymphoma Pipeline Companies based in Americas

  • Cancer
  • Lymphoma
  • World

Indolent Lymphoma R&D Pipeline Analysis Report, H2-2018

  • $ 2200
  • August 2018
  • 170 pages

Companies Investing in Indolent Lymphoma Pipeline include Number of Companies with Indolent Lymphoma projects in pre clinical Development Number of Companies with Indolent Lymphoma projects in Clinical Development Indolent Lymphoma Pipeline Companies based in Amer

  • Cancer
  • Lymphoma
  • World
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on